HBV-ISS (Dynavax).

Joseph J.�y. Sung, Henry Lik-YuenPubMed 2006

Abstract

Dynavax is developing HBV-ISS (Heplisav), a vaccine based on hepatitis B virus (HB V) antigens and Dynavax' s immunostimulatory DNA sequence (ISS) ISS-1018, an adjuvant that acts as a TLR-9 agonist, for the potential prevention and treatment of HBV infection.
BibTeX
@inproceedings{sung2006hbv,
  author = {Joseph J.�Y. Sung and Henry Lik-Yuen},
  title = {{HBV-ISS (Dynavax).}},
  booktitle = {PubMed},
  year = {2006},
}

Loading related content...

Figure